Results

eNauka >  Results >  Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
Title: Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
Authors Moens, Annick; ...; Milenkovic, Zoran; ...; (broj, koautora 25)
Issue Date: 2020
Publication: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
ISSN: 0269-2813 Alimentary Pharmacology and Therapeutics Search Idenfier
Type: Article
Collation: vol. 51 br. 1 str. 129-138
DOI: 10.1111/apt.15539
WoS-ID: 000494518700001
Scopus-ID: 2-s2.0-85074778397
URI: https://enauka.gov.rs/handle/123456789/804658
Project: Takeda Pharmaceutical Company Ltd
JanssenJohnson & Johnson USAJanssen Biotech Inc
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

117
SCOPUSTM
49
OpenCitations
97
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.